Stuckey, T., Grines, C. L., Cox, D. A., Garcia, E., Tcheng, J. E., Carroll, J., … Stone, G. W. (2001). Does stenting and glycoprotein IIb/IIIa receptor blockade improve the prognosis of diabetics undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 37(2), 342S-342S.

Stuckey, T., C. L. Grines, D. A. Cox, E. Garcia, J. E. Tcheng, J. Carroll, B. Rutherford, et al. “Does stenting and glycoprotein IIb/IIIa receptor blockade improve the prognosis of diabetics undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 1, 2001): 342S-342S.

Stuckey T, Grines CL, Cox DA, Garcia E, Tcheng JE, Carroll J, et al. Does stenting and glycoprotein IIb/IIIa receptor blockade improve the prognosis of diabetics undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2001 Feb 1;37(2):342S-342S.

Stuckey, T., et al. “Does stenting and glycoprotein IIb/IIIa receptor blockade improve the prognosis of diabetics undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 37, no. 2, ELSEVIER SCIENCE INC, Feb. 2001, pp. 342S-342S.

Stuckey T, Grines CL, Cox DA, Garcia E, Tcheng JE, Carroll J, Rutherford B, Guagliumi G, Esente P, Lansky AJ, Griffin J, Stone GW. Does stenting and glycoprotein IIb/IIIa receptor blockade improve the prognosis of diabetics undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2001 Feb 1;37(2):342S-342S.